February 14, 2020 — Esaote, an Italian company among the world leaders in the field of medical diagnostic imaging systems, is the Ducati Team's official partner for the 2020 season. The collaboration agreement between the two brands was signed today in Rome during the Esaote Global Sales and Marketing Meeting.

February 14, 2020 — The nuclear imaging equipment market in the Asia-Pacific (APAC) region is expected to grow at a compound annual growth rate (CAGR) of 8.9 percent from US$0.7B in 2019 to US$1.5B by 2028, according to GlobalData, a leading data and analytics company.

February 13, 2020 — The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from the U.S. Department of Veterans Affairs (VA) to develop quality indicators (QI) for radiation treatments provided to veterans with head and neck, breast and gastrointestinal cancers.

February 13, 2020 — MolecuLight Inc., a leader in handheld fluorescence imaging for real-time detection of bacteria in wounds, announced that the American Medical Association (AMA) has issued two new CPT category lll codes to enable a reimbursement pathway for point-of-care real-time fluorescence wound imaging for bacterial presence, location and load using the

February 13, 2020 — The U.S. Food and Drug Administration (FDA) cleared software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is an accessory to compatible diagnostic ultrasound systems and uses artificial intelligence to help the user capture images of a patient’s heart that are of acceptable diagnostic quality.

February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke, according to an ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR).

February 12, 2020 — The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000+ modalities.

February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the foreseeable future, due to surging demand for image-guided surgical procedures, according to a new report from Future Market Insights (FMI).

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now